Literature DB >> 24370685

Diverse roles of C-terminal Hsp70-interacting protein (CHIP) in tumorigenesis.

Chao Sun1, Hai-Long Li, Mei-Lin Shi, Qing-Hua Liu, Jin Bai, Jun-Nian Zheng.   

Abstract

BACKGROUND: The carboxyl terminus of Hsp70-interacting protein (CHIP) is a member of E3 ubiquitin ligase, functioning as a link between the chaperone (heat shock protein 70/90) and proteasome systems, playing a vital role in maintaining the protein homeostasis in the cytoplasm. CHIP has been demonstrated to be involved in tumorigenesis, proliferation and invasion in several malignancies, regulating a number of oncogenic proteins. However, CHIP has also been implicated in the modulation of tumor suppressor proteins. The pathogenic mechanism of CHIP expression in human malignancy is not yet clear, and a number of studies have suggested that CHIP may have opposing roles in different cancers. Therefore, many studies have focused on the relationship between CHIP and carcinoma.
METHODS: A literature search focusing on regulation network, biological function and clinical significance of CHIP in connection with its role in cancer development was performed on the MEDLINE databases. RESULTS AND
CONCLUSIONS: CHIP may be a potential diagnostic biomarker and therapeutic target for human cancer, and may play different roles in different human cancers. This inconsistence might be induced by the diversity of CHIP downstream targeting proteins. Therefore, the phenotypes determined by CHIP should be dependent on the function of its specific targets in a specific type of cancer cells. Whether CHIP contributes to tumor progression or suppression in various human cancers remains unclear, suggesting the necessity of further extensive investigation of its role in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370685     DOI: 10.1007/s00432-013-1571-5

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  101 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation.

Authors:  Claudia Esser; Martin Scheffner; Jörg Höhfeld
Journal:  J Biol Chem       Date:  2005-05-23       Impact factor: 5.157

3.  Inhibition of hsp70 by methylene blue affects signaling protein function and ubiquitination and modulates polyglutamine protein degradation.

Authors:  Adrienne M Wang; Yoshihiro Morishima; Kelly M Clapp; Hwei-Ming Peng; William B Pratt; Jason E Gestwicki; Yoichi Osawa; Andrew P Lieberman
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

4.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

Authors:  V M Richon; T W Sandhoff; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

Authors:  L N Klapper; H Waterman; M Sela; Y Yarden
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

7.  Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents.

Authors:  Nicolas Goasguen; Cecile de Chaisemartin; Antoine Brouquet; Catherine Julié; Gregoire P Prevost; Pierre Laurent-Puig; Christophe Penna
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

8.  Metastatic lymph node CHIP expression is a potential prognostic marker for resected esophageal squamous cell carcinoma patients.

Authors:  Jing Wen; Kong-Jia Luo; Yi Hu; Hong Yang; Jian-Hua Fu
Journal:  Ann Surg Oncol       Date:  2013-02-22       Impact factor: 5.344

9.  CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins.

Authors:  Yoshihiro Morishima; Adrienne M Wang; Zhigang Yu; William B Pratt; Yoichi Osawa; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2008-09-10       Impact factor: 6.150

10.  CHIP activates HSF1 and confers protection against apoptosis and cellular stress.

Authors:  Qian Dai; Chunlian Zhang; Yaxu Wu; Holly McDonough; Ryan A Whaley; Virginia Godfrey; Hui-Hua Li; Nageswara Madamanchi; Wanping Xu; Len Neckers; Douglas Cyr; Cam Patterson
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

View more
  21 in total

1.  Commentary: CHIPping away pancreatic tumors?

Authors:  Atul D Joshi; John D Catravas
Journal:  Ann Transl Med       Date:  2014-11

2.  CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.

Authors:  Y Shang; J He; Y Wang; Q Feng; Y Zhang; J Guo; J Li; S Li; Y Wang; G Yan; F Ren; Y Shi; J Xu; N Zeps; Y Zhai; D He; Z Chang
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

3.  Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP.

Authors:  Sukumar Sarkar; David L Brautigan; James M Larner
Journal:  Mol Cancer Res       Date:  2017-05-23       Impact factor: 5.852

4.  E3 ubiquitin ligase CHIP attenuates cellular proliferation and invasion abilities in triple-negative breast cancer cells.

Authors:  Jingjing Xu; Huan Wang; Wenjing Li; Kaili Liu; Tingli Zhang; Zhijie He; Feng Guo
Journal:  Clin Exp Med       Date:  2019-12-16       Impact factor: 3.984

5.  The E3 ubiquitin ligase CHIP/miR-92b/PTEN regulatory network contributes to tumorigenesis of glioblastoma.

Authors:  Tao Xu; Hongxiang Wang; Mei Jiang; Yong Yan; Weiqing Li; Hanchong Xu; Qilin Huang; Yicheng Lu; Juxiang Chen
Journal:  Am J Cancer Res       Date:  2017-02-01       Impact factor: 6.166

6.  The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance.

Authors:  Kuntal Biswas; Sukumar Sarkar; Kangping Du; David L Brautigan; Tarek Abbas; James M Larner
Journal:  Mol Cancer Res       Date:  2017-02-23       Impact factor: 5.852

7.  The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death.

Authors:  Lang Yoo; Kwang Chul Chung
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

8.  Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.

Authors:  Zibo Zhao; Lu Wang; Taryn James; Youngeun Jung; Ikyon Kim; Renxiang Tan; F Michael Hoffmann; Wei Xu
Journal:  Chem Biol       Date:  2015-12-03

9.  Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics.

Authors:  Zhiqiang Hu; Hamish S Scott; Guangrong Qin; Guangyong Zheng; Xixia Chu; Lu Xie; David L Adelson; Bergithe E Oftedal; Parvathy Venugopal; Milena Babic; Christopher N Hahn; Bing Zhang; Xiaojing Wang; Nan Li; Chaochun Wei
Journal:  Sci Rep       Date:  2015-07-09       Impact factor: 4.379

10.  CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma.

Authors:  Yuanqi Liu; Yanwu Zhou; Pengfei Zhang; Xizhe Li; Chaojun Duan; Chunfang Zhang
Journal:  Cell Death Differ       Date:  2020-10-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.